Panacea Biotec Limited (PANACEABIO.NS)

INR 544.6

(-1.37%)

Net Debt Summary of Panacea Biotec Limited

Panacea Biotec Limited's latest annual net debt in 2023 was -1.18 Billion INR , down -503.62% from previous year.
Panacea Biotec Limited's latest quarterly net debt in 2024 Q1 was - INR , up 100.0% from previous quarter.
Panacea Biotec Limited reported annual net debt of -196.3 Million INR in 2022, down -21.21% from previous year.
Panacea Biotec Limited reported annual net debt of -161.95 Million INR in 2021, down -102.11% from previous year.
Panacea Biotec Limited reported quarterly net debt of -163.7 Million INR for 2023 Q2, down -106.84% from previous quarter.
Panacea Biotec Limited reported quarterly net debt of 2.39 Billion INR for 2023 Q1, up 1319.61% from previous quarter.

Annual Net Debt Chart of Panacea Biotec Limited (2023 - 2004)

Historical Annual Net Debt of Panacea Biotec Limited (2023 - 2004)

Year	Net Debt	Net Debt Growth
2023	-1.18 Billion INR	-503.62%
2022	-196.3 Million INR	-21.21%
2021	-161.95 Million INR	-102.11%
2020	7.67 Billion INR	9.33%
2019	7.01 Billion INR	11.07%
2018	6.32 Billion INR	-31.62%
2017	9.24 Billion INR	-3.5%
2016	9.57 Billion INR	-7.54%
2015	10.35 Billion INR	7.2%
2014	9.66 Billion INR	9.94%
2013	8.79 Billion INR	-4.93%
2012	9.24 Billion INR	23.86%
2011	7.46 Billion INR	-8.17%
2010	8.12 Billion INR	23.47%
2009	6.58 Billion INR	4.81%
2008	6.28 Billion INR	157.54%
2007	2.43 Billion INR	415.79%
2006	472.88 Million INR	-66.54%
2005	1.41 Billion INR	-6.51%
2004	1.51 Billion INR	0.0%

Year	Net Debt	Net Debt Growth
2024 Q1	- INR	100.0%
2023 Q2	-163.7 Million INR	-106.84%
2023 Q1	2.39 Billion INR	1319.61%
2023 FY	-1.18 Billion INR	-503.62%
2023 Q4	-1.18 Billion INR	-164.42%
2023 Q3	1.83 Billion INR	1223.52%
2022 FY	-196.3 Million INR	-21.21%
2022 Q1	5.88 Billion INR	3732.48%
2022 Q2	-104 Million INR	-101.77%
2022 Q3	2.99 Billion INR	2980.96%
2022 Q4	-196.3 Million INR	-106.55%
2021 Q4	-161.95 Million INR	-111.47%
2021 Q2	7.4 Billion INR	445.54%
2021 FY	-161.95 Million INR	-102.11%
2021 Q1	1.35 Billion INR	-82.31%
2021 Q3	1.41 Billion INR	-80.94%
2020 FY	7.67 Billion INR	9.33%
2020 Q2	6.03 Billion INR	572.23%
2020 Q4	7.67 Billion INR	655.44%
2020 Q1	897.5 Million INR	-87.21%
2020 Q3	1.01 Billion INR	-83.16%
2019 Q4	7.01 Billion INR	499.97%
2019 Q3	1.17 Billion INR	-81.39%
2019 Q2	6.28 Billion INR	2577.47%
2019 Q1	234.8 Million INR	-96.28%
2019 FY	7.01 Billion INR	11.07%
2018 Q4	6.32 Billion INR	0.0%
2018 FY	6.32 Billion INR	-31.62%
2017 FY	9.24 Billion INR	-3.5%
2016 FY	9.57 Billion INR	-7.54%
2015 FY	10.35 Billion INR	7.2%
2014 FY	9.66 Billion INR	9.94%
2013 FY	8.79 Billion INR	-4.93%
2012 FY	9.24 Billion INR	23.86%
2011 FY	7.46 Billion INR	-8.17%
2010 FY	8.12 Billion INR	23.47%
2009 FY	6.58 Billion INR	4.81%
2008 FY	6.28 Billion INR	157.54%
2007 FY	2.43 Billion INR	415.79%
2006 FY	472.88 Million INR	-66.54%
2005 FY	1.41 Billion INR	-6.51%
2004 FY	1.51 Billion INR	0.0%

Peer Net Debt Comparison of Panacea Biotec Limited

Name	Net Debt	Net Debt Difference
Biocon Limited	140.18 Billion INR	100.845%
Blue Jet Healthcare Limited	-830.93 Million INR	-42.599%
Concord Biotech Limited	-54.04 Million INR	-2092.432%
Dishman Carbogen Amcis Limited	18.99 Billion INR	106.239%
Jubilant Ingrevia Limited	6.6 Billion INR	117.935%
Lyka Labs Limited	527.01 Million INR	324.833%
Piramal Pharma Limited	42.27 Billion INR	102.803%
SMS Lifesciences India Limited	992.31 Million INR	219.408%
Supriya Lifescience Limited	-694.68 Million INR	-70.568%
Syngene International Limited	-83 Million INR	-1327.59%
TAKE Solutions Limited	361.37 Million INR	427.891%
Zota Health Care Limited	942.79 Million INR	225.679%